|
Patient Safety/ Medical Error
Citations 51-60 of 103 total displayed.
|
Past content
(since May 1998):
|
- Research Letters
Bias in the Evaluation of Pharyngitis and Antibiotic Overuse
- Alexander Kiderman; Guy Marciano; Tali Bdolah-Abram; Mayer Brezis
Arch Intern Med 2009; 169: 524-525.
[Extract]
[Full text]
[PDF]
- Original Investigations
Overrides of Medication Alerts in Ambulatory Care
- Thomas Isaac; Joel S. Weissman; Roger B. Davis; Michael Massagli; Adrienne Cyrulik; Daniel Z. Sands; Saul N. Weingart
Arch Intern Med 2009; 169: 305-311.
[Abstract]
[Full text]
[PDF]
- Invited Commentary
Integrated Monitoring Systems and Patient Safety: A Need for Further Study—Invited Commentary
- Shashi Bellam
Arch Intern Med 2008; 168: 2404.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
No Black Box on Phosphosoda
- Michael Caswell
Arch Intern Med 2008; 168: 2285-a-2286-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Oral Sodium Phosphate Drug Products and Renal Function
- Kevin C. Abbott; Erin M. Bohen; Frank P. Hurst
Arch Intern Med 2008; 168: 2285.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Oral Sodium Phosphate and Renal Function—Reply
- Anand Khurana
Arch Intern Med 2008; 168: 2286-a-2287-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Oral Sodium Phosphate and Renal Function
- Lawrence B. Cohen
Arch Intern Med 2008; 168: 2286.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Participants in Phase 1 Oncology Research Trials Are Vulnerable
- Ron Berghmans
Arch Intern Med 2008; 168: 2287-2288.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Participants in Phase 1 Oncology Research Trials Are Vulnerable—Reply
- Christine Grady; Justine Seidenfeld; Elizabeth Horstmann; Ezekiel J. Emanuel
Arch Intern Med 2008; 168: 2288.
[Extract]
[Full text]
[PDF]
- Editorials
Glycemic Management of Type 2 Diabetes: How Tight Is Right and How to Get There
- David M. Nathan
Arch Intern Med 2008; 168: 2064-2066.
[Extract]
[Full text]
[PDF]
|
|
